Skip to main content
Clinical Trials/NCT03114059
NCT03114059
Completed
Not Applicable

Retro- and Prospective Monocentric Study to Evaluate the Safety and Effectiveness of the CyPass Stent 5 Years After Implantation

Dietrich-Bonhoeffer-Klinikum1 site in 1 country230 target enrollmentFebruary 1, 2017
ConditionsGlaucoma

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Glaucoma
Sponsor
Dietrich-Bonhoeffer-Klinikum
Enrollment
230
Locations
1
Primary Endpoint
Number of Patients That Achieve Target Intraocular Pressure Measured in mmHg
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

This study evaluates the results of all clinically relevant findings of glaucoma diagnostics 5 Years after stent-implantation concerning the safety and effectiveness of the cypass stent procedure. The comparison of Preoperative and long term postoperative results is the aim of this study to evaluate this young procedure of Glaucoma surgery

Detailed Description

This is a post market study without interventions.The participants have been treated with CyPass-Stent implantation between 3 and 7 years ago to control the intraocular pressure . They will be invited for only one follow up visit to determine the present glaucoma status again, to determine the long term safety and effectiveness of the cypass stent procedure and to see whether addition therapy or surgical intervention is necessary.

Registry
clinicaltrials.gov
Start Date
February 1, 2017
End Date
April 1, 2020
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Dietrich-Bonhoeffer-Klinikum
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • patients who have undergone a standalone cypass implantation at least 3 years ago
  • signed inform consent

Exclusion Criteria

  • Patients with too much travel distance between study center and home
  • Patients who cannot visit the studycenter due to health problems

Outcomes

Primary Outcomes

Number of Patients That Achieve Target Intraocular Pressure Measured in mmHg

Time Frame: up to 7 years

The Measurement of the intraocular Pressure is a criterion for the Efficacy of CyPass Stent Procedure (success rate). The postoperative target pressure of 15 mmHg, 18 mmHg or 21 mmHg (depends on Glaucoma Status) has to be achieved.

Change of Intraocular Pressure in mmHg Preoperatively (at Screening) vs Postoperatively (at Final Examination)

Time Frame: up to 7 years

The Measurement of the intraocular Pressure change is a criterion for the Efficacy of CyPass Stent Procedure (success rate). The postoperative pressure after 5 to 7 years has to be compared with the preoperative intraocular pressure (in mmHg) The change was calculated only from two time points. (value at the final examination time point minus the value at the preoperative time point

Number of Additional Medication

Time Frame: up to 7 years

The number of additional Glaucoma medication is another criterion to determine the Efficacy of CyPass Stent Procedure (success rate). Up to 4 different active substance can be used to reduce the pressure. The more substances the patient uses postoperatively the lower is the success after implantation of the CyPass-Stent. The postoperative number of medications after 5 years has to be compared with the preoperative number

Number of Participants With Secondary Glaucoma Procedures

Time Frame: up to 7 years

To determine the efficacy of CyPass Stent procedure completely the number of secondary glaucoma interventions (surgery/ laser) has to be documented

Secondary Outcomes

  • Number of Participants With Intra-and Postoperative Complications(up to 7 years)
  • Number of Participants With Stability of Optic Nerve(up to 7 years)
  • Number of Participants With Stability of Visual Field(up to 7 years)
  • Number of Participants With Stability of the Retinal Nerve Fiber Layer Thickness(up to 7 years)
  • Number of Participants With Stability of Stent Position(up to 7 years)
  • Number of Participants With Suprachoroidal Bleb(up to 7 years)
  • Number of Participants With Stability of Stent Tissue Interaction(up to 7 years)

Study Sites (1)

Loading locations...

Similar Trials